What have we learned from the expert consensus of antiplatelet therapy in cardiovascular disease?.
- Author:
Yong HUO
- Publication Type:Editorial
- MeSH: Cardiovascular Diseases; drug therapy; Humans; Platelet Aggregation Inhibitors; administration & dosage; adverse effects; therapeutic use
- From: Chinese Journal of Cardiology 2013;41(3):179-180
- CountryChina
- Language:Chinese